Valuation: Bide Pharmatech Co., Ltd.

Market Cap 5.77B 863M 774M 708M 646M 1.22B 81.16B 1.26B 8.53B 3.4B 43.31B 3.24B 3.17B 137B P/E 2024
37.2x
P/E 2025 35.3x
Enterprise Value 4.87B 729M 653M 597M 545M 1.03B 68.49B 1.06B 7.2B 2.87B 36.54B 2.73B 2.68B 115B EV / Sales 2024
2.94x
EV / Sales 2025 3.29x
Free-Float
41.34%
Yield 2024
1.83%
Yield 2025 1.9%
1 day-4.86%
1 week-0.10%
Current month-0.10%
1 month-12.62%
3 months+30.39%
6 months+8.63%
Current year+9.63%
1 week 60.01
Extreme 60.01
73.33
1 month 54.88
Extreme 54.88
75.72
Current year 43.21
Extreme 43.21
88.88
1 year 43.21
Extreme 43.21
88.88
3 years 28.5
Extreme 28.5
88.88
5 years 28.5
Extreme 28.5
114.05
10 years 28.5
Extreme 28.5
114.05
Manager TitleAgeSince
Chief Executive Officer 54 2023-10-12
Compliance Officer 38 2023-11-30
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 46 2023-10-12
Director/Board Member 63 2023-10-12
Chairman 54 2023-10-12
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Buy

Chief Executive Officer

450,000 0.4951%
9/4/26 Buy

Compliance Officer

15,000 0.0165%
1/22/26 Sell

Chief Executive Officer

24,264 0.0648%
Change 5-day change 1-year change 3-year change Capi.($)
-4.86%-0.10%-7.68%+1.50% 863M
-4.83%+3.51%+53.62%+61.75% 65.94B
-1.34%+2.98%+24.79%+100.18% 56.53B
+0.02%+1.07%+10.63%+76.66% 56.88B
+5.09%+9.89%+22.45%+107.48% 46.49B
+2.62%+1.68%+28.91%+37.01% 44.8B
+8.24%+0.51%+213.26%+792.66% 41.59B
-1.86%+10.13%+26.82%+53.22% 35.35B
-2.97%-9.84%+88.86%+76.17% 33.29B
-2.18%+7.06%+36.06%-4.95% 24.92B
Average -0.21%+3.00%+49.77%+130.17% 40.66B
Weighted average by Cap. +0.20%+3.40%+52.99%+142.66%

Financials

2024 2025
Net sales 1.1B 165M 148M 135M 123M 233M 15.51B 240M 1.63B 650M 8.28B 619M 606M 26.13B 1.32B 198M 178M 162M 148M 279M 18.63B 288M 1.96B 781M 9.94B 744M 728M 31.39B
Net income 117M 17.58M 15.77M 14.41M 13.16M 24.79M 1.65B 25.57M 174M 69.27M 882M 66M 64.58M 2.78B 152M 22.72M 20.38M 18.62M 17M 32.03M 2.14B 33.04M 224M 89.52M 1.14B 85.28M 83.46M 3.6B
Net Debt -1.1B -165M -148M -135M -123M -232M -15.46B -239M -1.63B -648M -8.25B -617M -604M -26.05B -900M -135M -121M -111M -101M -190M -12.67B -196M -1.33B -531M -6.76B -506M -495M -21.35B
Projected Income Statement - Annual - Bide Pharmatech Co., Ltd.
Logo Bide Pharmatech Co., Ltd.
Bide Pharmatech Co Ltd is a China-based company principally engaged in the research, development, production, and sales of drug molecular building blocks. The Company is mainly engaged in the research, development, production, and sales of drug molecular building blocks and scientific reagents, serving key stages of new drug research and development. The Company's main products are pharmaceutical molecular building blocks and scientific reagents. The Company's products are mainly applied in drug target discovery, lead compound synthesis and screening, lead compound discovery, synthesis and optimization, and other stages of new drug research and development. The Company mainly operates in the domestic and overseas markets.
Employees
734
Date Price Change Volume
26-11-06 CN¥66.93 -4.86% 4,683,249
26-11-05 CN¥70.35 +0.50% 6,576,669
26-11-04 CN¥70.00 +12.54% 7,179,943
26-11-03 CN¥62.20 -6.37% 7,380,465
26-11-02 CN¥66.43 -0.85% 8,692,817

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Bide Pharmatech Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 688073 Stock